| Trial Identifier: | D8540C00002 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT03811652 |
| Start Date: | December 2018 |
| Primary Completion Date: | December 2019 |
| Study Completion Date: | December 2019 |
| Condition: | Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| French Translation |
| Country | Location |
|---|---|
| Canada, ON | Toronto, ON, Canada, M5G 2M9 |
| United States of America, NC | Huntersville, NC, United States of America, 28078 |
| United States of America, TN | Nashville, TN, United States of America, 37203 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company